#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	17770	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2200	968.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1444	1444	C	1164	C,T	1162,2	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29840	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4234	880.0	0	.	n	.	0	T695C	SNP	695	695	T	1255	1255	C	1048	C,T,G,A	1045,1,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29840	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4234	880.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1897	1897	A	1172	A,G	1170,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29840	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4234	880.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2531	2531	C	1121	C,T,A	1119,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29840	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4234	880.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2605	2605	A	1064	A,G	1062,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29840	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4234	880.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	3157	3157	C	1032	C,G,T,A	1028,1,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	2494	folP	852	852	100.0	folP.l15.c4.ctg.1	2050	151.8	1	SNP	p	R228S	1	.	.	682	684	AGC	1307	1309	AGC	228;226;230	A,G;G;C	227,1;226;230	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6146	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3925	195.5	1	SNP	p	S91F	0	.	.	271	273	TCC	879	881	TCC	226;226;226	T,C;C,A;C	225,1;225,1;226	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6146	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3925	195.5	1	SNP	p	D95N	0	.	.	283	285	GAC	891	893	GAC	238;237;238	G;A,T,C;C	238;235,1,1;238	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6146	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3925	195.5	1	SNP	p	D95G	0	.	.	283	285	GAC	891	893	GAC	238;237;238	G;A,T,C;C	238;235,1,1;238	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	2246	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1918	146.2	0	.	p	.	0	A39T	NONSYN	115	117	GCC	766	768	ACC	220;220;222	A;C;C	220;220;222	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	2246	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1918	146.2	0	.	p	.	0	R44H	NONSYN	130	132	CGC	781	783	CAC	224;224;223	C;A,T;C,A	224;223,1;222,1	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	2246	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1918	146.2	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	964	966	CAC	309;308;308	C,T,A;A;C,G	306,1,2;308;307,1	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	2246	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1918	146.2	1	SNP	p	G45D	0	.	.	133	135	GGC	784	786	GGC	223;224;225	G;G;C	223;224;225	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1304	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c17.ctg.1	1351	119.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6262	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3471	225.3	1	SNP	p	D86N	0	.	.	256	258	GAC	810	812	GAC	313;312;311	G;A,C;C,T,G	313;311,1;309,1,1	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6262	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3471	225.3	1	SNP	p	S87R	0	.	.	259	261	AGT	813	815	AGT	308;310;314	A;G;T	308;310;314	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6262	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3471	225.3	1	SNP	p	S87W	0	.	.	259	261	AGT	813	815	AGT	308;310;314	A;G;T	308;310;314	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6262	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3471	225.3	1	SNP	p	S87I	0	.	.	259	261	AGT	813	815	AGT	308;310;314	A;G;T	308;310;314	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6262	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3471	225.3	1	SNP	p	S88P	0	.	.	262	264	TCC	816	818	TCC	316;317;320	T,G;C;C	314,2;317;320	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4968	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3166	195.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1787	1789	GGC	277;277;276	G;G,C;C,G	277;276,1;275,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4822	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2997	200.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1608	1610	GCA	300;299;299	G;C,G;A,G	300;297,2;298,1	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4822	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2997	200.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1611	1613	ATC	297;295;297	A,C;T;C	296,1;295;297	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4822	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2997	200.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1623	1625	GTG	301;302;305	G;T,G;G,C	301;301,1;304,1	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4822	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2997	200.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1623	1625	GTG	301;302;305	G;T,G;G,C	301;301,1;304,1	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4822	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2997	200.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2127	2129	ACC	284;286;286	A,G;C,G,A;C	283,1;284,1,1;286	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4822	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2997	200.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2181	2183	GCG	267;271;273	G,A;C;G,C	266,1;271;272,1	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4822	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2997	200.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2181	2183	GCG	267;271;273	G,A;C;G,C	266,1;271;272,1	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4822	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2997	200.9	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2304	2306	GGC	245;247;248	G;G;C	245;247;248	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4822	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2997	200.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2313	2315	GGC	241;240;242	G;G;C	241;240;242	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4822	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2997	200.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2331	2333	CCG	240;240;241	C,G;C;G,C	238,1;239;238,2	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6544	ponA	2397	2397	99.96	ponA.l6.c4.ctg.1	3502	233.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2948	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2408	152.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	796	796	C	234	C,G	233,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3408	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1745	240.5	0	.	p	.	0	E48G	NONSYN	142	144	GAA	598	600	GGA	306;305;309	G;G;A	306;305;309	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3408	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1745	240.5	0	.	p	.	0	F135L	NONSYN	403	405	TTT	859	861	CTT	272;273;274	C,G;T,G;T	271,1;272,1;274	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3408	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1745	240.5	0	.	p	.	0	R143G	NONSYN	427	429	AGA	883	885	GGA	272;270;270	G;G,C;A,C	272;269,1;269,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3408	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1745	240.5	0	.	p	.	0	D171G	NONSYN	511	513	GAT	967	969	GGT	264;264;264	G;G;T,G,C	263;263;262,1,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3408	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1745	240.5	0	.	p	.	0	G189S	NONSYN	565	567	GGC	1021	1023	AGC	289;289;290	A,G;G;C	288,1;289;290	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3408	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1745	240.5	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1087	1087	T	323	T	323	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3408	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1745	240.5	1	SNP	p	G120K	0	.	.	358	360	GGT	814	816	GGT	292;292;294	G;G;T	292;292;294	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3408	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1745	240.5	1	SNP	p	A121N	0	.	.	361	363	GCC	817	819	GCC	293;297;295	G;C;C	293;297;295	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3408	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1745	240.5	1	SNP	p	A121D	0	.	.	361	363	GCC	817	819	GCC	293;297;295	G;C;C	293;297;295	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11906	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5444	273.2	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2278	2280	AAT	293;293;291	A,C;A;T,A	292,1;293;290,1	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1722	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1396	154.0	1	SNP	p	V57M	1	.	.	169	171	ATG	727	729	ATG	305;307;306	A;T;G	305;307;306	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
